Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry.

Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry.

Item
http://www.wikidata.org/entity/Q34155229
Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA RegistryBenefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry.An observational, prospective, open-label, multicentre evaluation of aliskiren in treated, uncontrolled patients: a real-life, long-term, follow-up, clinical practice in Italy.Effectiveness and safety of aliskiren and aliskiren hydrochlorothiazide (HCT) in a multiethnic, real-world setting.Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control.Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A Registry.The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.Two-Year Outcomes of Patients Treated With Aliskiren Under Clinical Practice Conditions: Non-Interventional Prospective Study.
P2860

Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry.

Item
http://www.wikidata.org/entity/Q34155229
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Aliskiren for the treatment of ...... f the prospective 3A registry.
@ast
Aliskiren for the treatment of ...... f the prospective 3A registry.
@en
Aliskiren for the treatment of ...... f the prospective 3A registry.
@nl
type
label
Aliskiren for the treatment of ...... f the prospective 3A registry.
@ast
Aliskiren for the treatment of ...... f the prospective 3A registry.
@en
Aliskiren for the treatment of ...... f the prospective 3A registry.
@nl
prefLabel
Aliskiren for the treatment of ...... f the prospective 3A registry.
@ast
Aliskiren for the treatment of ...... f the prospective 3A registry.
@en
Aliskiren for the treatment of ...... f the prospective 3A registry.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Aliskiren for the treatment of ...... f the prospective 3A registry.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1742-1241.2012.02893.X
P433
P478
P577
P698